Prostatic Neoplasms: all 6,484 studies
Page 11 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)RecruitingNCT05893381Phase 2
- 64Cu-GRIP B in Patients With Advanced MalignanciesRecruitingNCT05888532Phase 1/2
- Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)RecruitingNCT05885009
- Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer PatientsRecruitingNCT05884632Not applicable
- Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)RecruitingNCT05882253Not applicable
- ASCVD Management Using CCTA in Prostate Cancer Patients on ADTRecruitingNCT05879913Not applicable
- Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate CancerRecruitingNCT05873192Phase 2
- Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination TherapyRecruitingNCT05869682Phase 2
- Two Fraction Prostate SBRT With DIL SIBRecruitingNCT05864196Phase 1
- Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mgNot yet recruitingNCT05856630Phase 1
- Multicenter, Prospective Clinical Study of the Serum Raman Spectroscopy Intelligent System for the Diagnosis of Prostate CancerRecruitingNCT05854940
- rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active SurveillanceRecruitingNCT05852041Early Phase 1
- Dose Escalation For INtraprostatic LEsionsRecruitingNCT05851547Phase 2
- To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES)Not yet recruitingNCT05851521Not applicable
- Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerRecruitingNCT05851365Early Phase 1
- Lifestyle Intervention in Patients With Metastatic Prostate CancerRecruitingNCT05850182Not applicable
- 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese PatientsRecruitingNCT05847348Phase 3
- A Phase 2/3,PSMA-T4, Prostate CancerRecruitingNCT05847166Not applicable
- Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer PatientsRecruitingNCT05841992Phase 2/3
- Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active SurveillanceRecruitingNCT05840484
- Vitamin D for Prostate Endocrine TherapyRecruitingNCT05838716Phase 3
- Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate CancerRecruitingNCT05832736Not applicable
- Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)RecruitingNCT05823402Not applicable
- The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate CancerRecruitingNCT05822726Not applicable
- PSMA PET Scan and mpMRI for Prostate Cancer DetectionNot yet recruitingNCT05820724Phase 2
- Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical ProstatectomyNot yet recruitingNCT05816668Phase 3
- The Active Surveillance StudyRecruitingNCT05810467
- Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationRecruitingNCT05806515Phase 2
- PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate CancerRecruitingNCT05805371Phase 1
- Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate CancerRecruitingNCT05804318Not applicable
- Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate CancerRecruitingNCT05803941Phase 4
- Akkermansia Muciniphilia and Metabolic Side Effects of ADTRecruitingNCT05802121Early Phase 1
- A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate CancerRecruitingNCT05800665Phase 1
- Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical ManagementRecruitingNCT05799248Phase 3
- Measuring Oncological Value of Exercise and StatinRecruitingNCT05796973Phase 3
- Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate AblationRecruitingNCT05790213Phase 2
- Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.RecruitingNCT05786742Not applicable
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsRecruitingNCT05786716Phase 2/3
- Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624RecruitingNCT05781217Phase 3
- Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)Not yet recruitingNCT05778097Phase 2
- Danish Prostate Cancer Consortium Study-1RecruitingNCT05767307
- Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate CancerRecruitingNCT05766371Phase 2
- RecoverPC: Relugolix vs GnRH Agonist in Quality of LifeRecruitingNCT05765500Phase 2
- High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate CancerRecruitingNCT05754580Not applicable
- Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate CancerRecruitingNCT05753566Phase 2
- Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative PainEnrolling by invitationNCT05753046Phase 4
- A Study on the Effects of Exercise Therapy on Signs of Prostate CancerRecruitingNCT05751434Phase 2
- A Study of Hansoh (HS)-10502 in Patients With Advanced Solid TumorsRecruitingNCT05740956Phase 1
- Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone MetastasesRecruitingNCT05740488Not applicable
- Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer PatientsRecruitingNCT05739565Not applicable
- A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate CancerRecruitingNCT05726292Phase 2
- Safety and Efficacy of Two-step Radical ProstatectomyRecruitingNCT05722392
- Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).RecruitingNCT05720130Phase 1/2
- Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT TreatmentNot yet recruitingNCT05717582Phase 2
- Focal Salvage Brachytherapy Study (FocaSaBra)RecruitingNCT05715502Not applicable
- Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer TreatmentRecruitingNCT05714774Not applicable
- Cost-utility of Focal HIFU vs ProstatectomyRecruitingNCT05710861Not applicable
- MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted BiopsyRecruitingNCT05710380Not applicable
- Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate CancerNot yet recruitingNCT05707468Not applicable
- TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate CancerRecruitingNCT05698576Not applicable
- Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine CellsRecruitingNCT05691465Phase 2
- Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate CancerNot yet recruitingNCT05681416Not applicable
- 99mTc-P137 SPECT/CT in Prostate CancerRecruitingNCT05672485Not applicable
- Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic ProstatectomyRecruitingNCT05669443Not applicable
- CART-PSMA Cells for Advanced Prostate CancerRecruitingNCT05656573Phase 1
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical TrialsRecruitingNCT05655494
- Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)AvailableNCT05650476
- PET/CT Characterization of Treatment ResistanceRecruitingNCT05647564Not applicable
- Antibody CC-1 in Men With Biochemical Recurrence of Prostate CancerRecruitingNCT05646550Phase 1
- LIVInG With chrONic Cancer TrEatments (LONGEVITI) StudyRecruitingNCT05645510
- Multidisciplinary Care After ProstatectomyNot yet recruitingNCT05644197Not applicable
- Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC StageRecruitingNCT05627752Phase 2/3
- Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND NetworkRecruitingNCT05627219
- Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate TumorRecruitingNCT05616650Phase 2
- Prostate Reirradiation Toxicity Outcomes Feasibility StudyNot yet recruitingNCT05614700Not applicable
- 177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate CancerRecruitingNCT05613738Not applicable
- A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRTRecruitingNCT05613023Phase 3
- Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused UltrasoundRecruitingNCT05610852Not applicable
- A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer SubjectsRecruitingNCT05607693Phase 1
- Prostate Cancer Screening With Abbreviated MRI ProtocolRecruitingNCT05603351Not applicable
- Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate CancerRecruitingNCT05600400Not applicable
- Using Rectal Hydrogel Spacer for Salvage SABR in Prostate CancerRecruitingNCT05597852Not applicable
- A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN LossRecruitingNCT05593497Phase 2
- Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate CancerRecruitingNCT05590624Not applicable
- Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyLRecruitingNCT05588128
- T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate CancerRecruitingNCT05586360Phase 2
- Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort AnalysisRecruitingNCT05584787Not applicable
- Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate CancerRecruitingNCT05582876Not applicable
- TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate CancerRecruitingNCT05582772Not applicable
- MDPK67b in Patients With Prostate CancerRecruitingNCT05580107Phase 1
- Novel Therapy Target in Metastatic Prostate CancerRecruitingNCT05577689
- Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical ProstatectomyNot yet recruitingNCT05576766Not applicable
- Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for CancerRecruitingNCT05574647Not applicable
- Pembro With Radiation With or Without OlaparibRecruitingNCT05568550Phase 2
- Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)RecruitingNCT05563558Phase 2
- Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized PatientsRecruitingNCT05558007Phase 2
- Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcerRecruitingNCT05557604Phase 2
- Tracer-Guided Surgery for Recurrent Prostate CancerRecruitingNCT05555017Phase 2
- PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - EnzalutamideRecruitingNCT05539300Not applicable
- Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate CancRecruitingNCT05534646Phase 2